World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on October 6, 2026

Oct. 6, 2026

Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply

Indeterminate GlobeNewswire

Oct. 6, 2026

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim

Indeterminate GlobeNewswire

Oct. 6, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Oct. 6, 2026

Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

Inventiva présentera plusieurs abstracts scientifiques lors de l’AASLD The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

Harvard Bioscience Announces Creation of Scientific Advisory Board

Indeterminate GlobeNewswire

Oct. 6, 2026

Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference

Indeterminate GlobeNewswire

Oct. 6, 2026

Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

115 Healthcare Professionals Graduate From First Medvarsity–GOAL Health Sciences Cohort in Guyana

Indeterminate EIN Presswire

Oct. 6, 2026

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire

Oct. 6, 2026

Acquisition of Own Shares

Indeterminate GlobeNewswire

Oct. 6, 2026

Inkoop van eigen aandelen

Indeterminate GlobeNewswire

Oct. 6, 2026

BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 6, 2026

FusionAuth Establishes UK Team as European Demand for Data Sovereignty Drives 72% Regional Growth

Indeterminate EIN Presswire

Oct. 6, 2026

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 6, 2026

Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers – CELH

Indeterminate GlobeNewswire

Oct. 6, 2026

reVolver Podcasts’ Contacto XIII Ranks Among Spotify Mexico’s Top 50 Science Podcasts

Indeterminate GlobeNewswire

Oct. 6, 2026

Ozari Health Launches Ozari One: Compounded Tirzepatide Online for $125 a Month, Same Price at Every Dose

Indeterminate GlobeNewswire